Shelton Capital Management bought a new stake in R1 RCM Inc. (NASDAQ:RCM – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 217,094 shares of the healthcare provider’s stock, valued at approximately $4,005,000. Shelton Capital Management owned 0.05% of R1 RCM as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Parkside Financial Bank & Trust boosted its position in shares of R1 RCM by 67.2% in the 1st quarter. Parkside Financial Bank & Trust now owns 2,972 shares of the healthcare provider’s stock valued at $45,000 after purchasing an additional 1,195 shares during the period. Rhumbline Advisers lifted its position in R1 RCM by 1.4% during the 1st quarter. Rhumbline Advisers now owns 478,625 shares of the healthcare provider’s stock worth $7,179,000 after acquiring an additional 6,501 shares during the period. Pier 88 Investment Partners LLC lifted its position in R1 RCM by 36.0% during the 1st quarter. Pier 88 Investment Partners LLC now owns 105,780 shares of the healthcare provider’s stock worth $1,587,000 after acquiring an additional 27,990 shares during the period. Twin Tree Management LP acquired a new stake in R1 RCM during the 1st quarter worth approximately $2,984,000. Finally, Voss Capital LLC lifted its position in R1 RCM by 374.1% during the 1st quarter. Voss Capital LLC now owns 814,403 shares of the healthcare provider’s stock worth $12,216,000 after acquiring an additional 642,613 shares during the period. 61.10% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts have weighed in on the company. Evercore ISI decreased their price objective on R1 RCM from $21.00 to $20.00 in a research report on Wednesday, October 11th. Guggenheim reissued a “buy” rating and issued a $21.00 price target on shares of R1 RCM in a report on Friday, July 21st. Truist Financial raised R1 RCM from a “hold” rating to a “buy” rating and set a $18.00 price target for the company in a report on Thursday, October 19th. Cantor Fitzgerald initiated coverage on R1 RCM in a report on Tuesday, August 15th. They issued an “overweight” rating and a $20.00 price target for the company. Finally, Royal Bank of Canada reduced their price target on R1 RCM from $22.00 to $19.00 and set an “outperform” rating for the company in a report on Friday, November 3rd. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, R1 RCM currently has an average rating of “Moderate Buy” and a consensus price target of $18.97.
R1 RCM Price Performance
Shares of NASDAQ:RCM opened at $10.67 on Friday. The company has a market cap of $4.47 billion, a P/E ratio of -118.54, a P/E/G ratio of 60.44 and a beta of 0.86. The company has a quick ratio of 1.80, a current ratio of 1.90 and a debt-to-equity ratio of 0.60. R1 RCM Inc. has a 52 week low of $7.13 and a 52 week high of $18.70. The business has a fifty day simple moving average of $13.06 and a 200-day simple moving average of $15.62.
R1 RCM Profile
R1 RCM Inc provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers.
- Five stocks we like better than R1 RCM
- Stock Market Sectors: What Are They and How Many Are There?
- MarketBeat Week in Review – 11/13 – 11/17
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 large caps with red hot RSIs with upside
- Most Volatile Stocks, What Investors Need to Know
- Johnson Controls International: Nothing but upside for investors
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.